Skip to main content
Top
Published in: International Journal of Colorectal Disease 9/2013

01-09-2013 | Original Article

Genotype–phenotype correlation in MMR mutation-positive families with Lynch syndrome

Authors: Lucía Pérez-Cabornero, Mar Infante, Eladio Velasco, Enrique Lastra, Cristina Miner, Mercedes Durán

Published in: International Journal of Colorectal Disease | Issue 9/2013

Login to get access

Abstract

Background

Hereditary nonpolyposis colorectal cancer (HNPCC) is caused by heterozygous mutations in mismatch repair (MMR) genes. Approximately 85 % of genetically defined HNPCC patients have germline mutations in MLH1 and MSH2. HNPCC patients are at increased risk of developing extracolonic cancers. The early age of onset, predominantly right-sided colon cancers, and synchronous and metachronous cancers are other features of the syndrome. HNPCC shows heterogeneous clinical phenotypes, and differences in gene mutation frequencies have been observed in some countries. Several investigators have tried to correlate the phenotype with the affected gene.

Methods

A total of 46 individuals from 22 unrelated families, of the 264 families fulfilling the inclusion criteria, with deleterious mutations in MLH1, MSH2, or MSH6 genes were identified. We evaluated these clinicopathological features in their relation to different genetic parameters (gene mutated, type of mutation, or alteration of the MMR system in high-risk families) in order to establish a relationship between the phenotype and the genotype in our series.

Results

The phenotype of the disease seems not to be influenced by the type of mutation, but rather by the mutated gene. The presence of multiple tumors is associated with mutations in the MSH2 gene. The mean age at diagnosis of the first colorectal cancer (CRC) was almost identical in families with mutations in MLH1 and MSH2, about 50 years of age, but this age may increase by almost 10 years for MSH6 mutation carriers.

Conclusion

The identification of genotype–phenotype correlations could provide a more specific surveillance program focused on the individualized risk.
Literature
1.
go back to reference Lynch HT, Smyrk TC, Watson P et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104:1535–1549PubMed Lynch HT, Smyrk TC, Watson P et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104:1535–1549PubMed
2.
go back to reference Jasperson KW, Tuohy TM, Neklason DW et al (2010) Hereditary and familial colon cancer. Gastroenterology 138(6):2044–58, ReviewPubMedCrossRef Jasperson KW, Tuohy TM, Neklason DW et al (2010) Hereditary and familial colon cancer. Gastroenterology 138(6):2044–58, ReviewPubMedCrossRef
3.
go back to reference Vasen HF, Wijnen JT, Menko FH et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020–1027PubMedCrossRef Vasen HF, Wijnen JT, Menko FH et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020–1027PubMedCrossRef
4.
go back to reference Peltomaki P (2001) Deficient DNA, mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10:735–740PubMedCrossRef Peltomaki P (2001) Deficient DNA, mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10:735–740PubMedCrossRef
5.
go back to reference Goecke T, Schulmann K, Engel C et al (2006) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 24(26):4285–92PubMedCrossRef Goecke T, Schulmann K, Engel C et al (2006) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 24(26):4285–92PubMedCrossRef
6.
go back to reference Vasen HF, Möslein G, Alonso A et al (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44:353–362PubMedCrossRef Vasen HF, Möslein G, Alonso A et al (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44:353–362PubMedCrossRef
7.
go back to reference Wang J, Luo MH, Zhang ZX et al (2007) Clinical and molecular analysis of hereditary non-polyposis colorectal cancer in Chinese colorectal cancer patients. World J Gastroenterol 13:1612–1617PubMed Wang J, Luo MH, Zhang ZX et al (2007) Clinical and molecular analysis of hereditary non-polyposis colorectal cancer in Chinese colorectal cancer patients. World J Gastroenterol 13:1612–1617PubMed
8.
go back to reference Nyström-Lahti M, Wu Y, Moisio AL et al (1996) DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 5:763–769PubMedCrossRef Nyström-Lahti M, Wu Y, Moisio AL et al (1996) DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 5:763–769PubMedCrossRef
9.
go back to reference Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829–834PubMedCrossRef Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829–834PubMedCrossRef
10.
go back to reference Velasco E, Infante M, Durán M et al (2007) Heteroduplex analysis by capillary array electrophoresis for rapid mutation detection in large multiexon genes. Nat Protoc 2:237–46PubMedCrossRef Velasco E, Infante M, Durán M et al (2007) Heteroduplex analysis by capillary array electrophoresis for rapid mutation detection in large multiexon genes. Nat Protoc 2:237–46PubMedCrossRef
11.
go back to reference Perez-Cabornero L, Velasco E, Infante M et al (2009) A new strategy to screen MMR genes in Lynch syndrome: HA-CAE, MLPA and RT-PCR. Eur J Cancer 45:1485–93PubMedCrossRef Perez-Cabornero L, Velasco E, Infante M et al (2009) A new strategy to screen MMR genes in Lynch syndrome: HA-CAE, MLPA and RT-PCR. Eur J Cancer 45:1485–93PubMedCrossRef
12.
go back to reference Vasen HF, Morreau H, Nortier JW (2001) Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 68:1533–1535PubMedCrossRef Vasen HF, Morreau H, Nortier JW (2001) Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 68:1533–1535PubMedCrossRef
13.
go back to reference Parc Y, Boisson C, Thomas G, Olschwang S (2003) Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet 40:208–213PubMedCrossRef Parc Y, Boisson C, Thomas G, Olschwang S (2003) Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet 40:208–213PubMedCrossRef
15.
go back to reference Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Moller P, Genuardi M, Van HH, Tops C, Van PM, Verkuijlen P, Kenter G, Van MA, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Wijnen JT, Brocker-Vriends AH, Vasen H (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance 2. Gastroenterology 127:17–25PubMedCrossRef Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Moller P, Genuardi M, Van HH, Tops C, Van PM, Verkuijlen P, Kenter G, Van MA, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Wijnen JT, Brocker-Vriends AH, Vasen H (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance 2. Gastroenterology 127:17–25PubMedCrossRef
16.
go back to reference Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S (2009) Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302:1790–1795PubMedCrossRef Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S (2009) Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302:1790–1795PubMedCrossRef
17.
go back to reference Baudhuin LM, Mai M, French AJ, Kruckeberg KE, Swanson RL, Winters JL, Courteau LK, Thibodeau SN (2005) Analysis of hMLH1 and hMSH2 gene dosage alterations in hereditary nonpolyposis colorectal cancer patients by novel methods. J Mol Diagn 7:226–235PubMedCrossRef Baudhuin LM, Mai M, French AJ, Kruckeberg KE, Swanson RL, Winters JL, Courteau LK, Thibodeau SN (2005) Analysis of hMLH1 and hMSH2 gene dosage alterations in hereditary nonpolyposis colorectal cancer patients by novel methods. J Mol Diagn 7:226–235PubMedCrossRef
18.
go back to reference Geary J, Sasieni P, Houlston R, Izatt L, Eeles R, Payne SJ, Fisher S, Hodgson SV (2008) Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC) 1. Fam Cancer 7:163–172PubMedCrossRef Geary J, Sasieni P, Houlston R, Izatt L, Eeles R, Payne SJ, Fisher S, Hodgson SV (2008) Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC) 1. Fam Cancer 7:163–172PubMedCrossRef
19.
go back to reference Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293:1979–1985PubMedCrossRef Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293:1979–1985PubMedCrossRef
20.
go back to reference Llor X, Pons E, Xicola RM, Castells A, Alenda C, Pinol V, Andreu M, Castellvi-Bel S, Paya A, Jover R, Bessa X, Giros A, Roca A, Gassull MA (2005) Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 11:7304–7310PubMedCrossRef Llor X, Pons E, Xicola RM, Castells A, Alenda C, Pinol V, Andreu M, Castellvi-Bel S, Paya A, Jover R, Bessa X, Giros A, Roca A, Gassull MA (2005) Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 11:7304–7310PubMedCrossRef
21.
go back to reference Ferreira S, Lage P, Sousa R, Claro I, Francisco I, Filipe B, Suspiro A, Chaves P, Rodrigues P, Albuquerque C, Nobre LC (2009) Familial colorectal cancer type X: clinical, pathological and molecular characterization. Acta Med Port 22:207–214PubMed Ferreira S, Lage P, Sousa R, Claro I, Francisco I, Filipe B, Suspiro A, Chaves P, Rodrigues P, Albuquerque C, Nobre LC (2009) Familial colorectal cancer type X: clinical, pathological and molecular characterization. Acta Med Port 22:207–214PubMed
22.
go back to reference Lindor NM (2009) Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome. Surg Oncol Clin N Am 18:637–645PubMedCrossRef Lindor NM (2009) Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome. Surg Oncol Clin N Am 18:637–645PubMedCrossRef
23.
go back to reference Jover MR (2008) Advances in colorectal cancer screening. Gastroenterol Hepatol Suppl 4:62–65CrossRef Jover MR (2008) Advances in colorectal cancer screening. Gastroenterol Hepatol Suppl 4:62–65CrossRef
24.
go back to reference Valle L, Perea J, Carbonell P, Fernandez V, Dotor AM, Benitez J, Urioste M (2007) Clinicopathologic and pedigree differences in Amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 25:781–786PubMedCrossRef Valle L, Perea J, Carbonell P, Fernandez V, Dotor AM, Benitez J, Urioste M (2007) Clinicopathologic and pedigree differences in Amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 25:781–786PubMedCrossRef
Metadata
Title
Genotype–phenotype correlation in MMR mutation-positive families with Lynch syndrome
Authors
Lucía Pérez-Cabornero
Mar Infante
Eladio Velasco
Enrique Lastra
Cristina Miner
Mercedes Durán
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Colorectal Disease / Issue 9/2013
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-013-1685-x

Other articles of this Issue 9/2013

International Journal of Colorectal Disease 9/2013 Go to the issue